Navigation Links
Abbott's HUMIRA(R) (adalimumab) Receives FDA Approval For Moderate to Severe Chronic Plaque Psoriasis
Date:1/18/2008

thritis and an EMEA regulatory application for HUMIRA to treat juvenile idiopathic arthritis. Clinical trials are currently underway evaluating the potential of HUMIRA in ulcerative colitis. HUMIRA is also approved for reducing signs and symptoms in patients with active AS. HUMIRA is approved for reducing the signs and symptoms and inducing and maintaining clinical remission in adults with moderately to severely active Crohn's disease who have had an inadequate response to conventional therapy and reducing signs and symptoms and inducing clinical remission in these patients if they have also lost response to or are intolerant to infliximab.

Abbott's Commitment to Immunology

Abbott is focused on the discovery and development of innovative treatments for immunologic diseases.

More information about HUMIRA, including full prescribing information and Medication Guide, is available on the Web site http://www.Rxabbott.com or in the United States by calling Abbott Medical Information at 1-800-633-9110.

About Abbott

Abbott is a global, broad-based health care company devoted to the discovery, development, manufacture and marketing of pharmaceuticals and medical products, including nutritionals and devices. The company employs 65,000 people and markets its products in more than 130 countries. Abbott's news releases and other information are available on the company's Web site at http://www.abbott.com.


'/>"/>
SOURCE Abbott
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Reclast(R) Receives US FDA Approval as First and Only Once-Yearly Treatment for Women With Postmenopausal Osteoporosis
2. Indevus Receives Approvable Letter From FDA for VALSTAR(R) for Bladder Cancer Therapy
3. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
4. Abbott Receives Supplemental FDA Approval for its Best-in-Class in Sensitivity RealTime HIV-1 Viral Load Test
5. GlaxoSmithKline Receives New HHS Order for H5N1 Bulk Antigen. First North American Clinical Trials with GSKs Candidate Pre-pandemic Flu Vaccine to Start.
6. CryoCor Receives FDA Approval for Right Atrial Flutter
7. Ranbaxy Receives Approval to Manufacture and Market Hydrocodone Bitartrate and Acetaminophen Tablets USP
8. Dimericine(R) Receives FDA Fast Track Designation for Treatment Of Photosensitivity in XP Patients
9. Poniard Pharmaceuticals Receives FDA Fast Track Designation for Picoplatin for Treatment of Small Cell Lung Cancer
10. Kosan Receives Completed Special Protocol Assessment for TIME-1 Pivotal Phase 3 Trial of Tanespimycin in Multiple Myeloma
11. The Female Health Company Receives USAID DELIVER PROJECT Order for 5 Million Units
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/18/2008)...lington Medical Resources (AMR), a,provider of pr...nd diagnostic,imaging industries, finds that over...n the U.S. during the third quarter of 2008. Privi...bulin (IVIG) and was launched in the first,quarte...d plasma of thousands,of donors and is used to tr...
(Date:11/18/2008)...f Influenza survey underscores that mothers need t... and Gold Medalist Kristi Yamaguchi joins initiati... While 78 percent of mothers in the United States ...hreatening disease that can strike anyone, only ha...ated this season, according to a new survey from t...
(Date:11/13/2008)...FirstCall/ -- Hologic, Inc.,(Nasdaq: HOLX ), a le...ium,diagnostics, medical imaging systems and surgi...eeds of women, today announced the results of the,... Cervista HPV high-risk,test is currently under re...launched in the European Union (EU) early in 2009....
(Date:11/13/2008)...s Cut Risk of Heart Attacks, Deaths, RESTON, Va.,... Disease,is the leading cause of death among Ameri...llions of dollars and causing untold suffering. No...ase - even among those who,weren,t thought to be a...eople could cut their risk of a,heart attack, stro...
Breaking Medicine Technology:Over $10 Million of CSL Behring's Privigen Was Sold in the U.S. During the Third Quarter of 2008 2Video: New Survey Finds Mothers See Influenza as a Serious Health Threat, but Often Don't Get Their Families Vaccinated 2Video: New Survey Finds Mothers See Influenza as a Serious Health Threat, but Often Don't Get Their Families Vaccinated 3Video: New Survey Finds Mothers See Influenza as a Serious Health Threat, but Often Don't Get Their Families Vaccinated 4Video: New Survey Finds Mothers See Influenza as a Serious Health Threat, but Often Don't Get Their Families Vaccinated 5Video: New Survey Finds Mothers See Influenza as a Serious Health Threat, but Often Don't Get Their Families Vaccinated 6Hologic Releases the Results of the Cervista(TM) HPV Clinical Trials 2Hologic Releases the Results of the Cervista(TM) HPV Clinical Trials 3Hologic Releases the Results of the Cervista(TM) HPV Clinical Trials 4Seniors Can Be Heartened by New Study on Statins 2Medical Industry Offers Food Ingredient Companies More Than One Billion Reasons to Think Healthy 7665 1Medical Industry Offers Food Ingredient Companies More Than One Billion Reasons to Think Healthy 7665 2Dads break bones of children more often than moms 7663 1Dads break bones of children more often than moms 7663 2FDA Panel Says No to Avastin for Advanced Breast Cancer 7661 1FDA Panel Says No to Avastin for Advanced Breast Cancer 7661 2FDA Panel Says No to Avastin for Advanced Breast Cancer 7661 3Scientists identify gene that influences alcohol consumption 7659 1Scientists identify gene that influences alcohol consumption 7659 2
...--(BUSINESS WIRE)--Apr 13, 2007 - Ascenta Therapeu... portfolio of,apoptosis-triggering compounds will ...l poster presentations at next week,s 2007,Annual ...earch,(AACR), to be held in Los Angeles, Californi...een selected for presentation at the,"High Impact ...
...ITY, April 13, 2007 /PRNewswire-FirstCall/ - AEter...utical company,focused on endocrine therapy and on...bstracts outlining first in vitro data on its,PI3K...tagonist,JMR-132, which both may potentially prov...f cancer. These abstracts will be,presented at the...
Other Medicine Technology:Ascenta Therapeutics Highlights Multiple Data Presentations at,Upcoming AACR Annual Meeting 2Ascenta Therapeutics Highlights Multiple Data Presentations at,Upcoming AACR Annual Meeting 3Ascenta Therapeutics Highlights Multiple Data Presentations at,Upcoming AACR Annual Meeting 4Ascenta Therapeutics Highlights Multiple Data Presentations at,Upcoming AACR Annual Meeting 5Ascenta Therapeutics Highlights Multiple Data Presentations at,Upcoming AACR Annual Meeting 6AEterna Zentaris To Present First In Vitro Data for PI3K Inhibitors,and In Vivo Results for a GHRH Antagonist at the AACR Annual,Meeting in Los Angeles 2AEterna Zentaris To Present First In Vitro Data for PI3K Inhibitors,and In Vivo Results for a GHRH Antagonist at the AACR Annual,Meeting in Los Angeles 3
(Date:11/21/2008)...e/ -- In a statewide survey, 33 physicians credent...ry at Presbyterian Hospital of Dallas were honored..." Super Doctors ." , , Each year, the publi...l Media, Inc. to survey more than 38,000 medical p... you needed medical care, which doctor would you c...
(Date:11/21/2008)...1 A prestigious group of physician...ther in Williamsburg, VA on March 27-29, 2009 at t... information on cutting-edge therapeutic protocols...arch advances that impact patient care. The full p...nformation is available at www.bioconferences.com...
(Date:11/21/2008)...e/ -- Innerscope Research(TM), a revolutionary,bi...nal Response Measurement,announced today the app...he,company,s research and development, business s...hree appointments, who deliver a combined 60 years...nancial Officer and Vice President of,Strategy; D...
(Date:11/21/2008)...The University of Texas M. D. Anderson Cancer Cent...to eradicate breast cancer in Panama through the P...h of the Americas today at an event with Laura Bus... Fernndez de Torrijos, the First Lady of Panama. ...the U.S. Department of State and Susan G. Komen fo...
Breaking Medicine News(10 mins):Health News:Annual List of 'Super Doctors' Features 33 Texas Institute for Surgery Physicians 2Health News:17th Annual Congress on Women's Health Convenes March 27-29, 2009 in Williamsburg, VA 2Health News:Innerscope Research Strengthens Management Team With Three Executive Appointments 2Health News:First Lady Laura Bush's Partnership for Breast Cancer Awareness and Research extends to Panama 2
...view that was published in the Friday’s issue of t... kids does not reduce their risk of fractures in t...of the maximum bone mass is got by the age of 18 y...ing bone mass at an early age might reduce the eff...
...to have developed a technique to find out if metas... liver.// <br.The research scientists at Wash...have developed a test for the prediction of whethe...r, where it could quickly transform into being ver...
... 'Raloxifene' can reduce postmenopausal women with...new study that has been published in the September... could protect postmenopausal women from developin... whether they are at high or low risk of developin...
...der, generation or income group, more and more peo...sus a gym and an exercise physiologist// at New Yo...center for sports medicine, thinks she knows why. ...t is safe, balanced, promotes fitness and importan...
Other Medicine News:Health News:Metastasis Of Ocular Melanoma To Liver Can Now Be Calculated 2Health News:Metastasis Of Ocular Melanoma To Liver Can Now Be Calculated 3Health News:Metastasis Of Ocular Melanoma To Liver Can Now Be Calculated 4Health News:Raloxifene Reduces The Risk Of Breast Cancer 2Health News:Raloxifene Reduces The Risk Of Breast Cancer 3Health News:Dance Your Way to a Better Body 2Health News:Dance Your Way to a Better Body 3
...cal IOL is a foldable silicone IOL. It features a ...e inserted with The UNFOLDER® Silver-T Implant... first and only FDA-approved multifocal IOL, and t...nal visionnear, intermediate, and far. The ARRAY&r...
...ferred viscoelastic for phacoemulsification proced...rks from the start to the finish of the case. The ...lastic is the reason. The low to moderate vacuum f...nly a fraction of the viscoelastic agent. However,...
...scoelastic agent for the surgeon who performs cata... Amvisc possesses sufficient viscosity for excelle... is highly cohesive so that complete removal at th...ed. Amvisc is priced to compete with any sodium hy...
...onate (1.8%) viscoelastic solution combines maximu...flo maintains a deep anterior chamber and protects... ideal for routine cataract surgery but can be use...lastic. Combine all these properties with the conv...
Medicine Products: